BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8026110)

  • 21. Diffuse form of idiopathic IgA nephropathy (IgAN). A quantitative study.
    Danilewicz M; Wagrowska-Danilewicz M
    Gen Diagn Pathol; 1996 Mar; 141(3-4):209-13. PubMed ID: 8705785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of IgA nephropathy: a repeat biopsy study.
    Hotta O; Furuta T; Chiba S; Tomioka S; Taguma Y
    Am J Kidney Dis; 2002 Mar; 39(3):493-502. PubMed ID: 11877568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of glomerular anionic charge status in children with IgA nephropathy using confocal laser scanning microscopy.
    Sakagami Y; Nakajima M; Takagawa K; Ueda T; Akazawa H; Maruhashi Y; Shimoyama H; Kamitsuji H; Yoshioka A
    Nephron Clin Pract; 2004; 96(3):c96-104. PubMed ID: 15056992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
    Weber CL; Rose CL; Magil AB
    Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy.
    Kusano T; Takano H; Kang D; Nagahama K; Aoki M; Morita M; Kaneko T; Tsuruoka S; Shimizu A
    Hum Pathol; 2016 Mar; 49():135-44. PubMed ID: 26826420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features and prognosis of IgA nephropathy with glomerular crescents].
    Wan X; Li JG; Bai J; Huang HH; Su XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):336-9. PubMed ID: 17425986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Severe proteinuria in IgA nephropathy. Clinicopathological study of 8 cases with 100 serial sections].
    Shouno Y; Shimokama T; Sakemi T; Harada A; Watanabe T
    Nihon Jinzo Gakkai Shi; 1993 Sep; 35(9):1043-50. PubMed ID: 8230814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Semiquantitative histological evaluation of IgA nephropathy and Cox's proportional Hazzard model analysis].
    Nakao N
    Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1063-70. PubMed ID: 1808358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy.
    Wu J; Chen X; Xie Y; Yamanaka N; Shi S; Wu D; Liu S; Cai G
    Nephrol Dial Transplant; 2005 Apr; 20(4):719-27. PubMed ID: 15701667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular diseases and their risk factors in IgA nephropathy.
    Myllymäki J; Syrjänen J; Helin H; Pasternack A; Kattainen A; Mustonen J
    Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of small crescents in IgA nephropathy: analysis of four patients showing a deteriorated renal function during a long follow-up period.
    Hotta O; Taguma Y; Kurosawa K; Sudo K; Suzuki K; Horigome I
    Clin Nephrol; 1993 Sep; 40(3):125-30. PubMed ID: 8403565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Structure of segmental tuft lesions in childhood IgA nephropathy--three dimensional analysis indicates development of segmental lesions].
    Akioka Y
    Nihon Jinzo Gakkai Shi; 1994 Sep; 36(9):973-81. PubMed ID: 7967181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S; Söderberg MP; Berg UB
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP; van den Brand JA; Wetzels JF
    Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of vascular lesions in IgA nephropathy and their influencing factors, a study of 1,005 cases].
    Wu J; Chen XM; Shi SZ
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(4):289-93. PubMed ID: 12812644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
    Roos A; Rastaldi MP; Calvaresi N; Oortwijn BD; Schlagwein N; van Gijlswijk-Janssen DJ; Stahl GL; Matsushita M; Fujita T; van Kooten C; Daha MR
    J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O; Watier L; Rossert J; Stengel B;
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grading of acute and chronic renal lesions in Henoch-Schönlein purpura.
    Szeto CC; Choi PC; To KF; Li PK; Hui J; Chow KM; Leung CB; Lui SF; Mac-Moune Lai F
    Mod Pathol; 2001 Jul; 14(7):635-40. PubMed ID: 11454994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.